This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Pharma trade targeted by Chinese regulators in antitrust push on scarce drugs, raw ingredients

By MLex Staff ( August 4, 2017, 08:03 GMT | Insight) -- China's National Development and Reform Commission and other Cinese regulators are drafting new guidelines to regulate the pricing of medicines that are in short supply and raw materials used to make medicines. The aim is to tackle price gouging and antitrust violations, and one of the most important elements of the initiaitive will be a blacklist system to ban companies that repeatedly breach antitrust law from the market for scarce drugs and raw materials.China's National Development and Reform Commission and other Cinese regulators are drafting new guidelines to regulate the pricing of medicines that are in short supply and raw materials used to make medicines, with the aim of tackling price gouging and antitrust violations....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections